Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers

Fig. 2The alternative text for this image may have been generated using AI.

Immune cells in the microenvironment of SCLC. a Analysis of macrophages (Mφs)/monocytes. A total of 7 Mφ subtypes, 2 monocyte subtypes and 1 dendritic cell subtype were identified (left panel). The distribution of cells across different sample types is shown in the right panel. b Dot plot of selected gene expression in each cell lineage. Dot size and color indicate the fraction of expressing cells and normalized expression levels, respectively. c-e Boxplots representing the relative proportions of each Mφ/monocyte population. Comparisons were made among different stages classified by TNM stage (c), smoking status (d), and outcomes of neoadjuvant therapy (e). f Analysis of T/NK cells. A total of 14 subtypes of T/NK cells were identified (left panel). The distribution of cells in different sample types is shown in the right panel. g Boxplots representing the relative proportions of each T/NK cell subtype. Comparisons were made among different stages and outcomes of neoadjuvant therapy. h Analysis of B cells. A total of 9 subtypes of B cells were identified (left panel). The distribution of cells across different sample types is shown in the right panel. i Boxplots representing the relative proportions of each B cell subtype. Comparisons were made among different stages and outcomes of neoadjuvant therapy. P values in (c, d, e, g, and i) were determined via the Wilcoxon rank-sum test. *P < 0.05, **P < 0.01

Back to article page